- Home
- BJDX vs QNRX Comparison
BJDX vs QNRX Comparison
Compare BJDX & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BJDX
- QNRX
- Stock Information
- Founded
- BJDX 2015
- QNRX 2018
- Country
- BJDX United States
- QNRX United States
- Employees
- BJDX N/A
- QNRX N/A
- Industry
- BJDX Medical Specialities
- QNRX Medical/Dental Instruments
- Sector
- BJDX Health Care
- QNRX Health Care
- Exchange
- BJDX Nasdaq
- QNRX Nasdaq
- Market Cap
- BJDX 2.2M
- QNRX 2.5M
- IPO Year
- BJDX 2021
- QNRX N/A
- Fundamental
- Price
- BJDX $3.53
- QNRX $0.23
- Analyst Decision
- BJDX
- QNRX
- Analyst Count
- BJDX 0
- QNRX 0
- Target Price
- BJDX N/A
- QNRX N/A
- AVG Volume (30 Days)
- BJDX 74.7K
- QNRX 11.2M
- Earning Date
- BJDX 05-14-2025
- QNRX 05-08-2025
- Dividend Yield
- BJDX N/A
- QNRX N/A
- EPS Growth
- BJDX N/A
- QNRX N/A
- EPS
- BJDX N/A
- QNRX N/A
- Revenue
- BJDX N/A
- QNRX N/A
- Revenue This Year
- BJDX N/A
- QNRX N/A
- Revenue Next Year
- BJDX $55.56
- QNRX N/A
- P/E Ratio
- BJDX N/A
- QNRX N/A
- Revenue Growth
- BJDX N/A
- QNRX N/A
- 52 Week Low
- BJDX $3.03
- QNRX $0.21
- 52 Week High
- BJDX $316.80
- QNRX $1.57
- Technical
- Relative Strength Index (RSI)
- BJDX 43.84
- QNRX 39.89
- Support Level
- BJDX $3.52
- QNRX $0.21
- Resistance Level
- BJDX $4.02
- QNRX $0.42
- Average True Range (ATR)
- BJDX 0.43
- QNRX 0.04
- MACD
- BJDX -0.07
- QNRX -0.00
- Stochastic Oscillator
- BJDX 26.59
- QNRX 11.05
Stock Price Comparison Chart: BJDX vs QNRX
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.